BridgeMD
New treatment option for Stroke
Official title Comprehensive Intensive Stroke Rehabilitation
ClinicalTrials.gov ID: NCT05323916
What this study is testing
- What it's testing
- In this study, the investigators aim to assess the effectiveness of the Comprehensive Intensive Rehabilitation Program After Stroke implementing the International Classification of Functioning, Disability and Health model, and to compare it with two cohorts receiving Comprehensive Intensive Rehabilitation Program After Stroke of the same length but different in physical therapy content (program implementing modern technological approach and neuroproprioceptive "facilitation and inhibition"). Moreover, control group will undergo standard care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- adults
- after first ischemic stroke
- early sub-acute phase
- slight to moderately severe disability [2 - 4 on the Modified Rankin Scale]
- 0 - 2 on the Pre-Stroke Modified Rankin Score
You likely can't join if
- low level of consciousness (vegetative state and/or minimally conscious state); severe cognitive decline that would interfere with administration of...
- behavioural disorders and/or lack of cooperation with therapist
- severe medical problems with a poor prognosis, (e.g., severe frailty, advanced and incurable cancer, fracture, cardiovascular disorders as chronic...
See the full eligibility criteria
- adults
- after first ischemic stroke
- early sub-acute phase
- slight to moderately severe disability [2 - 4 on the Modified Rankin Scale]
- 0 - 2 on the Pre-Stroke Modified Rankin Score
- potential to accept 4 hours of comprehensive rehabilitation per day and to profit from physiotherapy
- minimal or moderate motor deficit of upper or lower extremities (on NIHSS Item 5 or 6 scores 1-3 points)
- able to perform activities of daily living prior to stroke event (0 - 2 on the Pre-Stroke Modified Rankin Score)
- Czech is participants' native language or its knowledge is at the level of the mother tongue
- low level of consciousness (vegetative state and/or minimally conscious state); severe cognitive decline that would interfere with administration of the tests, premorbid illiteracy, severe visual and/or auditory deficit...
- behavioural disorders and/or lack of cooperation with therapist
- severe medical problems with a poor prognosis, (e.g., severe frailty, advanced and incurable cancer, fracture, cardiovascular disorders as chronic heart failure NYHA III, IV, symptomatic coronary artery disease Angina...
The study team makes the final eligibility decision.
Where it's taking place
- Prague, Czechia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Prague, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.